Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Federico

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 11, 2023
Pneumococcal vaccination status among cirrhotic patients in Italy: a neglected topicTommaso Stroffolini, Alessia Ciancio, Alessandro Federico, et al.
Journal of Clinical Gastroenterology|August 8, 2008
Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized studyAngelo Andriulli, Matteo Neri, Carmelina Loguercio, et al.
Reviews on Recent Clinical Trials|June 30, 2020
Light Alcohol Drinking and the Risk of Cancer Development: A Controversial RelationshipGiuseppe G Caprio, Desiree Picascia, Marcello Dallio, et al.
Gastroenterology|April 9, 2013
Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistanceJavier Molina-Infante, Marco Romano, Miguel Fernandez-Bermejo, et al.
International Journal of Cancer|April 16, 2022
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumabGiulia Martini, Davide Ciardiello, Marcello Dallio, et al.
Helicobacter|April 22, 2020
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life studyMarco Romano, Antonietta Gerarda Gravina, Gerardo Nardone, et al.
Hepatology (Baltimore, Md.)|March 12, 2024
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver diseaseAlfredo Marchetti, Serena Pelusi, Alessio Marella, et al.
Antiviral Therapy|February 7, 2017
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimensNicola Coppola, Stefania De Pascalis, Vincenzo Messina, et al.
European Journal of Gastroenterology & Hepatology|April 28, 2023
Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinomaRaffaella Tortora, Nunzia Farella, Filomena Morisco, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|January 21, 2026
Synbiotic Supplementation for Chronic Constipation in Patients Under Peritoneal Dialysis: An Italian Multicenter Prospective StudyGennaro Argentino, Giuseppe Paribello, Andrea Foderini, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 11, 2023
Pneumococcal vaccination status among cirrhotic patients in Italy: a neglected topicTommaso Stroffolini, Alessia Ciancio, Alessandro Federico, et al.
Journal of Clinical Gastroenterology|August 8, 2008
Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized studyAngelo Andriulli, Matteo Neri, Carmelina Loguercio, et al.
Reviews on Recent Clinical Trials|June 30, 2020
Light Alcohol Drinking and the Risk of Cancer Development: A Controversial RelationshipGiuseppe G Caprio, Desiree Picascia, Marcello Dallio, et al.
Gastroenterology|April 9, 2013
Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistanceJavier Molina-Infante, Marco Romano, Miguel Fernandez-Bermejo, et al.
International Journal of Cancer|April 16, 2022
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumabGiulia Martini, Davide Ciardiello, Marcello Dallio, et al.
Helicobacter|April 22, 2020
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life studyMarco Romano, Antonietta Gerarda Gravina, Gerardo Nardone, et al.
Hepatology (Baltimore, Md.)|March 12, 2024
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver diseaseAlfredo Marchetti, Serena Pelusi, Alessio Marella, et al.
Antiviral Therapy|February 7, 2017
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimensNicola Coppola, Stefania De Pascalis, Vincenzo Messina, et al.
European Journal of Gastroenterology & Hepatology|April 28, 2023
Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinomaRaffaella Tortora, Nunzia Farella, Filomena Morisco, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|January 21, 2026
Synbiotic Supplementation for Chronic Constipation in Patients Under Peritoneal Dialysis: An Italian Multicenter Prospective StudyGennaro Argentino, Giuseppe Paribello, Andrea Foderini, et al.
Pageof 20